SANTA BARBARA, Calif., Sept. 20, 2022 /PRNewswire/ — Bexson Biomedical, Inc., a biopharmaceutical company focused on disrupting the $189 billion small molecule injectable market and enabling home health solutions, today announced the appointment of Robert S. Langer ScD, MIT David H. Koch Institute Professor and Co-founder of Moderna, to its Scientific Advisory Board (SAB). “We are excited to have…


Previous articlePT357 – Dr. Hans Eriksson – Precision Psychiatry, Ketabon, and The Stress Response System
Next articleCOMPASS Pathways to participate in upcoming Jefferies Innovation in Mental Health Summit